Entities

Clinical-stage biotech developing radiopharmaceuticals for solid and hematologic malignancies, with molecules entering trials and more targets in discovery.

Designs and manufactures highly engineered aerospace parts and subsystems—actuators, switches, hydraulics, and power electronics—by combining legacy suppliers with modern engineering. Headquartered in El Segundo, California.

Bispecifics for B-cell cancers, metabolic disease, and HBV. Founded 2021. Palo Alto. Later acquired by AstraZeneca.

AI-native platform that automates internal audit, including end-to-end control testing across SOX, operational, and compliance controls.

Defense products company building autonomous systems for the U.S. and allies. Founded 2017. Costa Mesa, California.

Precision medicines company spun out of Scorpion Therapeutics, developing first-in-class small-molecule drugs for cancer and other serious diseases. Launched in 2025. Headquartered in Boston.

Software company providing development kits, AI tools and engineering services for autonomy and software-defined systems.

AI hardware engineer (Atlas) for electronics testing. $30M Series B with Founders Fund.

Human-centric password and credentials platform for consumers and businesses. Founded 2005. Toronto.

Axiom Therapeutics develops covalent medicines using quantum-accurate molecular simulations and machine learning. Its computational drug-discovery platform designs compounds that bind durably to disease-related proteins, aiming to make previously difficult drug targets treatable and improve the potency and selectivity of new therapies. Founded by medicinal and computational chemists from Cambridge, the London-based company combines drug-design research with chemistry expertise to develop medicines for diseases that lack effective treatments.

Deepset operates in AI.

Emm operates in Healthcare.

Multiplayer game-server infrastructure.

Healthcare company.

Company operating in AI.

Molecule reduces friction and accelerates science. Fund biotech research, discover DeSci projects, and access tokenized intellectual property on the leading decentralized science platform.

Company operating in Data & Analytics.

Company operating in Biotech & Life Sciences.

Company operating in Climate & Energy.

Builds visual AI systems for scientific laboratories and other regulated workplaces. Its Lumi platform uses computer vision to monitor experiments and equipment, capture laboratory activity, flag issues and generate records, helping scientists improve traceability and spend less time on manual observation and documentation.

Company operating in Developer Tools.

Wasp operates in Developer Tools.

Company operating in Cybersecurity.

Aito Technologies developed customer-experience analytics software that unified business, network, product and customer data for mobile operators; EXFO acquired its assets in 2014.

Cint provides research and measurement technology, including a programmatic marketplace that connects researchers and advertisers with survey respondents worldwide.

Edgeware developed video-delivery infrastructure for broadcasters and telecom operators, including purpose-built servers and content-delivery technology for high-quality television streaming at scale.

IPtronics designed high-speed integrated circuits for parallel optical interconnects before its acquisition by Mellanox Technologies.

itslearning provides a cloud learning-management system used by schools and higher-education institutions to manage teaching, content, assessment, and communication.

JAYS is a Swedish consumer-audio brand that designs headphones, earphones, and speakers.

A Swedish manufacturer of silicon-carbide wafers for power-semiconductor applications, fully acquired by STMicroelectronics in 2019.

Spotify is a digital music service that gives you access to millions of songs.

TrustWeaver developed cloud software for legally compliant electronic invoicing, digital signatures and VAT compliance; Sovos acquired it in 2018.

Videoplaza developed a video advertising management and monetization platform for broadcasters and digital publishers; it was acquired by Ooyala.

Xtract provided social-intelligence and customer-analytics software to mobile operators, using network behavior to support marketing and churn reduction; Comptel acquired it in 2012.

Autobutler is a European online marketplace where vehicle owners compare repair and service quotes from vetted garages.

13th Lab was a Stockholm computer-vision startup whose technology created real-time 3D models of physical environments for mobile and virtual-reality applications; Oculus acquired it in 2014.

JustBook developed an online booking service for hotels and travel accommodation.

Food & Agriculture company.

Tictail operates in E-Commerce & Marketplace.

Wrapp operates in Consumer.

Moderne Kassensysteme als App für Zahlungsannahme und Umsatzverfolgung: Machen Sie sich Ihren Geschäftsalltag mit PayPal Point of Sale leichter.

Instabridge operates in Consumer.

Commure builds the financial infrastructure for modern health systems, with an AI-native revenue cycle platform that automates end-to-end RCM and turns manual administrative work into scalable software—enabling durable growth and better care outcomes.

Opbeat built application-performance monitoring software for JavaScript developers; Elastic acquired the company and used its team and technology to expand Elastic APM.

Challenge your brain with Peak, the No.1 app for your mind. Push your cognitive skills to their limits and use your time better with fun, challenging games and workouts that test your Focus, Memory, Problem Solving, Mental Agility and more.

HR & Talent company.

PlayRaven was a Finnish mobile-game studio focused on strategy games and was acquired by Rovio.

Gaming company.

AI company.

Automatiserat bokföringsprogram där du enkelt kan göra din bokföring online på egen hand. Fakturerings- och löneprogram med automatisk bokföring ingår.

AI company.

Healthcare company.

Consumer company.

Comtravo operates in Travel & Hospitality.

Cornershop operates in E-Commerce & Marketplace.

Depop operates in E-Commerce & Marketplace.

Mobility & Transportation company.

Media & Entertainment company.

Futureplay is a Helsinki-based mobile game studio that develops and publishes free-to-play games.

Honest Food Company built delivery-only restaurant brands and kitchens for the European market and later became part of Delivery Hero.

KNL Networks developed long-range, secure radio communications and data-networking technology for maritime and remote operations.

Education company.

Klarna operates in Fintech.

Customer-support quality automation.

Kry operates in Healthcare.

Stock-trading API for developers. Founded 2020. Berlin.

Magmatic Games was a mobile casual-game studio founded by veterans of the Forces of Freedom team; it created Travel Town and was acquired in 2021.

Data & Analytics company.

Logistics & Supply Chain company.

Resolution Games is a Stockholm based studio focused on creating virtual reality (VR) and augmented reality (AR) immersive experiences for all.

Syft was a flexible-staffing marketplace that connected hospitality employers directly with vetted, rated temporary workers; Indeed acquired the company.

Fintech company.

Virta Health is the leader in diabetes reversal and sustainable weight loss. Discover personalized, nutrition-first care designed for lasting results.

Vivino operates in E-Commerce & Marketplace.

Xeneta is the leading ocean and air freight rate benchmarking and market intelligence platform, using crowdsourced data to deliver real-time pricing, capacity, and index insights that help shippers, forwarders, and carriers benchmark, plan, and negotiate better.

Amie operates in SaaS.

Watch the world's best CS2 teams compete at BLAST Premier. Find upcoming tournaments, buy tickets, and find all the arena info tyou need here

Fintech company.

E-Commerce & Marketplace company.

cargo.one is a digital marketplace for booking and marketing air cargo capacity. Founded in 2017, it lets freight forwarders search, compare, and instantly book real-time rates across 60+ airlines, and is trusted by 20,000+ forwarders in 134 countries.

Power insights and outcomes with The Elasticsearch Platform. See into your data and find answers that matter with enterprise solutions designed to help you accelerate time to insight. Try Elastic toda...

SaaS company.

Healthcare company.

Insurance company.

Founded in 2016, Mavenoid builds an AI agent for product support focused on physical products. The platform automates diagnostics and deflection, and escalates to live video assistance when needed, helping companies resolve complex issues faster, prevent unnecessary replacements, and improve customer experience across channels.

Healthcare company.

Follow up and follow through from your Gmail: personalized sequences, per-person tracking, tasks, and one-click booking. Free to start — no credit card.

Offer embedded financial products inside the software businesses use every day

European spend-management platform for companies. Founded 2015 in Copenhagen by Jeppe Rindom and Niccolo Perra.

REKKI connects restaurants with their suppliers, letting chefs browse products, place and track orders, chat in real time, and handle payments in one place. Suppliers use REKKI to streamline order intake and get paid faster, with AI‑powered tools that reduce errors and bad debt.

Support the community you love

Shapr3D builds a cross-platform, direct-modeling CAD app for iPad, Mac, Windows, and Apple Vision Pro. It brings precise, touch-friendly modeling to designers and engineers, streamlining sketching, 3D modeling, and drawings, with robust import/export for manufacturing workflows and integration with major CAD formats.

Swan operates in Defense & Space.

Fintech company.

Fintech company.

Easily deploy high-level code to your ESP32 and run them in containers.

German mobile brokerage and savings platform founded in 2015 by Christian Hecker, Thomas Oukropeck, and Marco Cancellieri. HQ Berlin.

Twaice operates in Climate & Energy.

unitQ operates in Data & Analytics.

Vay operates in Mobility & Transportation.

Voi operates in Mobility & Transportation.

Insurance company.

Abacum operates in Enterprise Software.

E-Commerce & Marketplace company.

Enterprise Software company.

TypeScript feature management that gets you back to building, faster.

Developer Tools company.

Enode operates in Climate & Energy.

Fuse Energy operates in Climate & Energy.

Powering how capital works. The layer between founders and finance through AI.

Gopuff operates in Consumer.

AI company.

Fintech company.

Discover the ultimate HR software platform your team will love. Streamline your processes and boost productivity. Get started today!

Lunar X is a global digital content studio spanning hit shows, music catalogues, live events & commerce

Modal operates in Developer Tools.

Mobility & Transportation company.

SaaS company.

A customer platform where commercial teams work better. We build and deploy frontier technologies—integrating data, AI and collaboration—that empower industry leaders to acquire and grow lifelong revenue.

Procuros builds an AI-powered B2B Integration Hub for retail and FMCG, unifying EDI, APIs, and supplier portals to exchange orders, delivery notes, and invoices seamlessly with thousands of partners.

Food & Agriculture company.

Cybersecurity company.

Insurance company building health and travel coverage for digital nomads, remote workers and globally distributed teams.

The only Notified Body specialised in software and AI - a medical device certification process built for SaMD and AIaMD manufacturers.

Logistics & Supply Chain company.

Fintech company.

Dollar and euro accounts for global fintechs and banks.

We closed a Series A last year (Creandum leading, with YC + fmc doubling down) and are processing over $1B a year, with 3 more pay-in markets in 2026.

CAST AI operates in Infrastructure & Cloud.

Codesphere operates in Infrastructure & Cloud.

Developer Tools company.

Fintech company.

H Company operates in AI.

Junction (formerly Vital) is a healthcare infrastructure platform that unifies lab testing and wearable device data through a single API. It streamlines ordering, results, and device connectivity with automated workflows and real-time updates.

AI company.

Developer Tools company.

Lindus Health operates in Health.

AI company.

Construction company.

Data & Analytics company.

Enterprise Software company.

Sereact develops VLA AI that acts as a production-ready brain for robots, enabling zero-shot autonomy in real-world warehouses and industrial settings. Its system lets robots see, reason, and manipulate varied items across arms, mobile manipulators, and more.

Create, launch, and iterate performance ad campaigns with AI. Generate video ads, copy, and creative assets in minutes.

At terralayr, we're not just offering storage and batteries; we're pioneering a new era of energy flexibility. In a world where renewable energy is on the rise, the need for flexibility in energy storage has never been more crucial. That's where we come in.

AI company.

Healthcare company.

Ares runs AI interviews across your entire workforce to discover what's broken and distills hundreds of conversations into a clear, intelligent path forward.

Black Forest Labs operates in AI.

Fintech company.

Cerrion operates in Enterprise Software.

Enterprise Software company.

Fintech company.

Data & Analytics company.

GetVocal provides governable conversational AI agents for enterprise contact-center and customer-service workflows.

Build profitable AI clouds. Monetize GPU infrastructure. Ultra efficient GPUaaS, optimized GPU utilization, capacity sharing, 5x more revenue & margin per GPU.

HR & Talent company.

SaaS company.

Fintech company.

Building the infrastructure for frontier AI.

null

Milan platform automating financial operations for Italian SMBs.

Enterprise Software company.

Houston and Palo Alto biodata company combining low-cost RNA sequencing with generative models that predict disease course and drug response. Founded in 2023 by David Zhang and Ashwin Gopinath.

Robotic wind-turbine inspection and maintenance.

Federated AI platform for clinical research. Sends algorithms to data instead of moving patient records. Founded 2020 by Blaise Thomson and Naaman Tammuz.

Proximity-inducing compounds (PICs) for diseases with high unmet need.

AI agents for pharmaceutical drug launches, pricing and reimbursement workflows.

Brooklyn company building sorbent filters to recover critical minerals from domestic waste streams. Spun out of UC Berkeley.

Software for businesses and financial institutions transitioning fleets to net-zero emissions.

Antibody-based drugs aimed at solid tumors.

AI and chemical robotics for materials discovery in the energy transition.

Cell-free biomanufacturing using enzymes on natural materials to replace petrochemical products. Founded 2018 by Grant Aarons and Ferdinando Randisi.

First-in-class microbiome therapies, including gut-brain axis research.

Therapeutics for endometrial disease using a 3D endometrial modeling platform from the Yale Sozen Lab. Co-founded by Ashley Abel, Berna Sozen and Kathy Potts.

Formerly Aluminio. Builds tools and consumables to replace silver with base metals on silicon solar cells.

Cancer prediction and prevention.

Nuclear recycling company converting spent fuel into long-duration radiovoltaic power sources. Founded by Stafford Sheehan.

AI-driven molecular glue discovery. Founded by Chris Tame.

On-site synthesis of carbon-neutral chemicals from point-source CO2.

Engineered geologic hydrogen from mineral reactions underground.

Digital patient twins and virtual simulations for medical-device development.

Associate at Pace Ventures focused on early-stage health-tech and industrial-tech investments in Europe and the United States.

Associate at Pace Ventures focused on early-stage health-tech and industrial-tech investments in Europe and the United States.

Facebook and Asana co-founder who now serves as secretary and treasurer of Good Ventures, the philanthropic foundation he created with Cari Tuna.

Anthropic co-founder and former OpenAI researcher who was a technical lead on GPT-3.

Anthropic co-founder and interpretability researcher, formerly an interpretability lead at OpenAI.

Co-founder and chief technology officer of Anthropic; previously led AI-safety research at OpenAI.

Historical cryptocurrency-exchange operating company. SEC release dated2022-12-13 identifies the exchange; its corporate investments must be distinguished from a standalone venture capital investment firm. This classification does not assert current operating status.

President and co-founder of Anthropic; previously vice president of safety and policy at OpenAI.

Founder of Metaplanet, investor and philanthropist focused on technologies and initiatives that reduce long-term existential risk; previously a founding engineer of Skype.

Anthropic co-founder and policy leader; previously policy director at OpenAI and a technology journalist.

Anthropic co-founder and chief science officer, known for research on neural-network scaling laws.

CEO and co-founder of Anthropic; previously vice president of research at OpenAI.

MGX is an Abu Dhabi-based private investment platform backing and building companies across artificial intelligence and advanced technology worldwide. Its strategy spans semiconductors, AI infrastructure, and AI applications and enabling platforms, including software, technology-enabled services and life sciences. It pairs capital with operational expertise to develop scalable platforms and long-term partnerships. Established in March 2024 by Abu Dhabi’s Artificial Intelligence and Advanced Technology Council, the platform comprises ADGM-incorporated MGX Group Holding 1 Ltd and its owned, ADGM FSRA-regulated MGX Fund Management Limited. Published group-board governance is distinguished from the fund manager’s leadership and is not proof that each group director holds a statutory directorship at the manager.

Neuroimaging researcher at Lys specializing in functional near-infrared spectroscopy and diffuse optical tomography.

Machine learning at Lys. Fulbright scholar; site lists CMU PhD in Robotics. Fulbright Bulgaria profile describes a 2022-23 visiting researcher stay at CMU Robotics Institute while completing a PhD at Technical University of Sofia.

Engineer at Lys with a background in competitive programming, working on the company's non-invasive neurotechnology platform.

Co-founder of Lys with a research background in computational astrophysics.

Physics specialist at Lys and a gold medalist at the 2016 International Physics Olympiad.

Co-founder of Lys and former co-founder of conversational-AI company Chai Research.

CEO of Lys with an academic background in brain-computer-interface research and neuroscience.

Consumer character-chatbot platform (Chai AI). Founded in Cambridge, relocated to Palo Alto.

Physician, co-founder and co-CEO of Komodo Health, where he oversees data science, engineering and product development.

Co-founder and AI/ML lead at Cogitat, developing machine-learning methods for decoding EEG brain signals.

Physician, computer scientist and GV advisor focused on healthcare data, diagnostics and therapeutics; formerly chief data officer at Foundation Medicine. Serves as Advisory Board Member at Paradigm Health, according to its current team directory. Current GV source qualification: Gaurav Singal is a physician, computer scientist and GV adviser whose current individual biography is published outside the firm’s main team directory. Previously served as Foundation Medicine chief data officer, developing genomic and clinical-data products. Earlier created natural-language tools for reviewing patient records at Mass General Brigham. Holds Columbia computer-science and Harvard-MIT medical degrees and practices medicine at Brigham and Women’s Hospital.

Co-founder and data/ML lead at Cogitat, developing machine-learning systems for EEG-based brain-computer interfaces.

Co-founder and neuroinformatics lead at Cogitat and a neuroinformatics researcher at Aristotle University of Thessaloniki.

Pathologist, co-founder and CEO of PathAI, where he applies machine learning to pathology and biomedical research.

Professor of neurology at Harvard Medical School, division chief of epilepsy at Mass General Brigham and co-director of MGH's Center for Neurotechnology and Neurorecovery.

Co-founder and scientific lead at Cogitat and professor of machine learning and computer vision at Imperial College London.

Co-founder and CTO of Beacon Biosignals, building machine-learning and software systems for EEG-based neuroscience research.

Dr Navid Mohammadi Foumani is Foundation Model Architect & Lead at Dcode.AI and works at Emotiv / Emotiv Research in Melbourne. He is lead author of EEG2Rep (KDD 2024 Audience Appreciation Award) and EEG-X (arXiv:2511.08861). GitHub and Google Scholar list affiliations as Monash University and Emotiv.

Physician-scientist, co-founder and CEO of Beacon Biosignals, applying AI-powered EEG analytics to neurological, psychiatric and sleep disorders.

Patrick Chu is VP of Software Engineering at Dcode.AI and VP of Engineering at Emotiv. The Dcode.AI team page says he has over 20 years in neurotechnology and leads development of Dcode's core platform. LinkedIn places him in Hong Kong.

Craniofacial surgeon and co-founder and CEO of Cogitat, a company developing EEG-based brain-computer-interface technology.

Co-founder and CTO of Emotiv, where he develops wearable EEG systems and cognitive-AI infrastructure.

Founder and CEO of Emotiv, building wearable EEG systems, brain-data platforms and cognitive-AI infrastructure.

Chicago private investment firm investing in seed and Series A stage businesses as well as venture buyouts.

Co-founder and CTO of Cogitat, developing neuroinformatics and machine-learning systems for EEG brain-computer interfaces.

Former venture capital firm investing in technologies for neurological and psychiatric disorders, including neurotechnology, brain-computer interfaces, neuromodulation, diagnostics and digital care. Its team combined medical-device engineering, clinical neurology and company-building experience to support ventures from seed incubation through growth financing. The firm states that its operations concluded on March 31, 2026; the people listed here held historical Nexus roles.

General partner at Pace Ventures, investing in pre-seed and seed health-tech and industrial-tech companies across Europe and the United States.

Managing partner and co-founder of Supermoon Capital, a venture firm focused on sleep and circadian health; previously co-founded Nevro.

Co-founder and COO of Neurable, commercializing brain-computer-interface technology for consumer products and partnerships.

Co-founder and managing director of Adverb Ventures; previously chief product officer at Slack and a product and partnerships leader at Twitter.

Partner at Fifth Growth Fund, investing in consumer, media and technology companies.

Co-founder and managing director of Adverb Ventures; previously a general partner at GV and vice president of corporate development and strategy at Twitter.

Founder and managing partner of Lionheart Ventures and a two-time technology entrepreneur; previously founded Zesty and co-founded GroupSpaces.

Co-founder and CTO of Arctop, with a background in full-stack engineering, cybersecurity and cognitive-research infrastructure.

Co-founder and CEO of Neurable, which develops brain-computer-interface technology for everyday products.

Co-founder and chief product officer of Piramidal, developing foundation models for clinical neurophysiology data; previously led products at Google and Spotify.

Neuroscientist, co-founder and CEO of Arctop, developing software that decodes non-invasive brain signals.

Founder and CEO of Piramidal, building foundation models for clinical EEG and neurophysiology data; previously led deep-learning work at IQVIA.

Fifth Growth Fund is a Dallas-based growth-stage venture firm investing in media, entertainment, and consumer technology companies. The firm is led by media executive Ed Wilson.

Early-stage venture firm co-founded by Jessica Verrilli and April Underwood; invests from idea through Series A.

Munich-based early-stage firm investing up to about €100k globally, pre-seed through Series A.

Lionheart Ventures is an early-stage venture capital firm specializing in artificial intelligence and frontier mental-health technologies. Its mental-health practice backs psychedelic medicines, neuromodulation and other approaches intended to improve care, while its AI practice invests in technologies that support human agency, resilience and safety. The firm evaluates both commercial opportunity and the potential effects of transformative technology on human flourishing. Its published team combines founders and operators with neuroscience, clinical-development, regulatory, intellectual-property and AI-safety expertise, supporting companies through investment, technical advice and founder networks.

Co-founder and CTO of Hemispheric, developing large AI models that decode non-invasive brain activity; previously co-founded RealFace and worked on Face ID and Vision Pro at Apple.

Computational neuroscientist, co-founder and CEO of Hemispheric, developing AI models to quantify and decode non-invasive brain activity.

Assistant professor of practice at the University of Texas at Austin School of Information whose work spans machine learning, natural-language processing and deep learning; he also advises nubrain.

Cognitive neuroscientist and co-founder of nubrain, working on machine-learning systems that decode language and other information from non-invasive EEG.

Physician and cognitive-neuroscience researcher at the University of Jena who advises nubrain on non-invasive brain-computer-interface work.

Assistant professor of cognitive neuroscience at Maastricht University whose research examines neural representations and visual cognition; he also advises nubrain.

Co-founder and CEO of nubrain, developing foundation models that decode non-invasive brain signals into text, images and other structured outputs.

Co-founder and CTO of Restack, building infrastructure and agents for enterprise AI automation; also an angel investor in nubrain.

Chief technology officer at Vercel and an angel investor in nubrain; previously created AMP while at Google.

Founder and CEO of hLevel, an AI startup focused on financial markets; previously head of applied AI at Goldman Sachs and a mathematical logician.

Framework for reliable AI agents. Co-founded by Philippe Brulé (CTO) and Andrés Tapia (CEO).

Partner on Creandum's Stockholm investment team, with a product-focused investing practice developed over more than two decades at the firm.

Partner on Creandum's Stockholm investment team, backing technology companies from early stage onward.

Partner on Creandum's London investment team, focused on early-stage technology companies.

Partner on Creandum's Berlin investment team, investing in early-stage technology companies.

Founding partner on Creandum's Stockholm investment team, backing early-stage European technology companies.

Partner on Creandum's San Francisco investment team, supporting technology founders across Europe and the United States.

Advisor at Creandum in London and former CEO of Depop, with operating and board experience across consumer technology and media.

Partner at Creandum focused on healthcare and technology investments, with prior operating experience in digital health.

Fintech entrepreneur, investor and network partner at Creandum, advising founders and investing in financial-technology companies.

Partner at CREANDUM

Venture Partner at CREANDUM

Investment Manager at CREANDUM

Associate at CREANDUM

Partner at CREANDUM

Wallonie Entreprendre (WE) is Wallonia’s regional public financing and investment group, organized as Belgian public-interest company Wallonie Entreprendre SA, enterprise BE0793.630.244. Its public mission combines patient equity, loans, guarantees and business support across company stages. The official Belgian registry proves that WE legally absorbed SRIW (BE0219.919.487), SOWALFIN and SOGEPA on January9,2023; this is legal succession, rather than a simple shared regional brand. Its Venture Capital expertise combines Life Sciences and Digital Deeptech, investing in biotechnology, medical devices, digital health, artificial intelligence, cybersecurity and research commercialization. Historical issuer investment references to SRIW and SRIW Life Sciences are preserved as predecessor/team attribution within the verified successor platform; a particular subsidiary or fund cash payer is not guessed. The group’s current public governance directory lists executive and board affiliations separately, while the dated Q4 2024 Life Sciences roster documents six investment professionals; current tenure is qualified where no newer employer roster confirms it. SPARAXIS SA, BE0452.116.307, is a separate WE-related governance entity in the audited annual report, not WE’s enterprise number. Its board representation is not treated as personal capital or proof of an issuer check. The latest annual report describes corporate investments and public financing rather than an external LP fund close; holdings values, annual deployed capital, guarantee totals and five-year strategy targets are not recorded as new fundraising. The retained InvestmentFirm classification represents the public investment platform and does not imply a private venture partnership.

The Alzheimer’s Drug Discovery Foundation (ADDF) is a US public charity using venture philanthropy and mission-related investments to advance drugs, diagnostics and prevention for Alzheimer’s disease and related dementias. Its scientific portfolio includes fluid, retinal and digital/AI biomarkers, clinical trials and neurotherapeutics; financial returns are reinvested in its mission. The Delaware nonprofit was incorporated in April2004 (EIN20-1082179), with the Lauder family’s earlier Alzheimer’s research philanthropy as historical context. It is a 501(c)(3) public charity, not a conventional VC manager or private foundation. The current staff directory names IsobelColeman CEO and LauraNisenbaum interimCSO; HowardFillit is cofounder/CSO emeritus. DiagnosticsAccelerator, launchedJuly2018, reports100MUSD philanthropic commitments, not an LP fund close or proof allpledges have been paid. The audited2024 statements distinguish approved contracted mission-related investment payables from cash received/paid and report financial returns only when received. The published team includes staff, governors, overseers and clearly marked honorary/in-memoriam affiliations; these are not all operating employees.

iSeed Ventures is the San Francisco venture firm whose exact legal adviser is iSeed Ventures LLC, a Delaware limited liability company, CRD297342 / SEC802-114472. Its 6 March 2026 Form ADV independently links iseedvc.com and the iseedventures LinkedIn company page to the same adviser and reports the office at 150 Spear Street, Suite725, San Francisco. It reports as an exempt reporting adviser; this is not a claim of SEC endorsement or investment-adviser registration. The retained Adex iSeed record is enriched without changing its immutable InvestmentFirm type or protected investment identities. Similar iSeed-branded India/China investors are not automatically assigned this adviser’s legal identity. The firm’s own company profile says it was founded in2014 and focuses on technology-first companies, particularly AI and its applications across enterprise, healthcare, fintech and consumer sectors. Primary company releases establish actual healthcare/neuroscience backing: Neurotrack’s 27 January2016 USD6.5M new financing includes iSeed Ventures, and mySugr’s 11 March2015 release identifies the manager as an early-stage digital-health investor with US and China core markets. These company-wide round totals are not iSeed’s disclosed individual checks. A Final Round AI founder’s public financing acknowledgment names the same LLC and Adam Lin; exact transaction allocation remains a separate issuer audit. The current contact-only website publishes an authentic firm logo but no named team or portfolio directory. The March2026 legal filing names Adam How Lin as managing member/chief compliance officer and Yang Cheng as a member/control person, both appointments reported October2014 without an exact day. The own LinkedIn company page separately names Bryan Cheng as an employee without a title. A legal/public alias bridge between Bryan and Yang has not been established, so no duplicate person or assumed general-partner title is created. Authentic individual portraits and a complete operating roster remain public-source gaps. The unrelated Gunderson lawyer Adam Lin and Delos associate Yang Cheng are preserved as distinct people. Current ADV identifies FundI and FundIII, including the separately named GP III LLC. A primary 17 May2024 FormD identifies Delaware2023 FundIV with USD100M sold to one investor against USD150M offered, first sale19December2023; this is a reported sold snapshot, not an invented final close or USD150M of paid subscriptions. FundIV shares the exact office/telephone and Adam Lin GP-management identity, but is absent from the latest adviser’s private-fund list; current adviser coverage is therefore unconfirmed. The own LinkedIn USD200M-plus AUM claim and ADV private-fund asset values are not new fundraising or allocated company cash. FundII appears in historical listed-company transaction material, but its current mandate and cash corpus are not inferred. All five protected prior checks remain unchanged.

Innovate UK is the United Kingdom’s public innovation agency and a component of UK Research and Innovation (UKRI). It supports businesses developing and commercialising new products, processes and services through innovation grants, loans, investor partnerships and business support. Its remit spans AI and digital technologies, advanced manufacturing, life sciences, clean energy and other research-intensive industries. Its Executive Leadership Board runs the organisation; a separate Council provides external advice. The inherited InvestmentFirm database type is retained for compatibility: this institution is a public funding agency rather than a private venture-capital partnership. Government programme allocations and aggregate project spending are not external LP fund closes. Legacy financing links are preserved; links to a company’s equity round do not alone prove an agency equity subscription or its check amount.

Commerce-platform operating company providing infrastructure and tools for businesses to sell online and in person. Corporate investments are distinct from a standalone venture capital firm or separately named venture affiliate.

Polaris Partners is a U.S. venture-capital and company-building platform founded in1996 by Jon Flint, Terry McGuire and Steve Arnold, with current public offices in Boston, New York, San Francisco and Singapore. It invests across biotechnology, healthcare technology, medical devices and technology companies. Its healthcare-AI and neuroscience portfolio includes Cohere Health, PathAI, Faro AI, Noetik, Akili, Neumora, Noema Pharma, Muna Therapeutics, QurAlis and Matter Neuroscience; portfolio lists can include former, indirect and affiliate co-investments and do not establish a cash amount or stage by themselves. The current public main directory names30 investment, entrepreneurial, legal, finance and operations professionals. April8,2026 legal disclosures identify North Star Venture Management2026 LLC (formerly North Star Venture Management2010 LLC) and North Star Venture Management Legacy LLC as the main-fund managers, alongside Singapore entity North Star Ventures SG Pte Ltd. Specialized Innovation Funds are managed by LS Polaris Innovation Fund Management LLC and Growth Funds by Polaris Growth Management LLC. Existing separate Polaris Innovation Fund identity is preserved; this profile describes the main Polaris brand rather than merging affiliate records. Funds I–XI and the Healthcare Technology Opportunities Fund are named in primary disclosures. Fund VIII actually closed at USD435M announcedMay4,2017. Fund X disclosed USD354,590,909 sold including GP commitments asofApril21,2023, a subscriptions snapshot rather than an asserted finalclose or its USD355M offering ceiling. Fund XI’s October21,2025 filing records zero sold and a USD500M offering target, which is excluded from closedcapital. Aggregate AUM, portfolio company cumulative financing and fund targets are not extra fund closes. Existing corporate and personal investment relationships remain preserved, including source-qualified Cohere, BeMe and Noema checks. Unrelated Japanese, Danish, Swiss, Canadian and former Israeli Polaris-name firms are not aliases of this manager.

GD1, short for Global From Day One, is an Auckland venture capital firm backing New Zealand founders building businesses for global markets. Its operator-led team invests from first pre-seed cheques through Series B and combines a generalist mandate with expertise in hardware, healthcare, frontier technologies, software and financial infrastructure. Current themes include industrial energy and materials, reusable space systems, diagnostics and medical devices, vertical AI and agentic software, and financial infrastructure. The firm helps founders with technical execution, international sales and subsequent financing. Its published portfolio includes Dawn Aerospace, Foundry Lab, Alimetry, Auror and Ivo. It also operates a distinct Web3 strategy and a Select investment vehicle for later-stage investments in existing portfolio companies.

G Squared is a global venture capital firm that invests in growth-stage technology businesses and supplies liquidity to their shareholders while companies remain private. It buys shares through direct secondary transactions, structures company-led employee and investor tender offers, provides bespoke capital solutions and participates in selected primary financings. Founded in 2011, it works directly with management teams on liquidity programs and uses fundamental company research to build concentrated positions. Its public portfolio spans AI, data infrastructure, cybersecurity, application software, fintech, consumer platforms, mobility and frontier technologies, including Anthropic, Physical Intelligence, Lambda, Nscale, SpaceX and X-energy. The firm operates from Chicago, San Francisco, Miami and Zurich.

Ascend is a Seattle pre-seed venture-capital firm founded by Kirby Winfield in 2019. It backs primarily Seattle-area founders building vertical AI agents and applications, horizontal generative-AI infrastructure and AI for physical-world problems. The firm helps founders connect with customers, talent and later-stage venture investors. Its public team includes Founding General Partner Kirby Winfield, Partner and Chief of Staff Jen Haller, and Nate Bek, promoted to Senior Associate and Head of Content. Thomas Stahura, its former analyst, remains affiliated as an emeritus associate according to Winfield’s current announcement. Published portfolio companies include Kamiwaza, Overland AI, Sabi, Hearvana, Neon Health, Outbound AI, WhyLabs, Bytewax and Yoodli. Ascend’s published preferred initial check range is $250,000–$750,000; this is a strategy range rather than a disclosed ticket for each investment. Its Seattle funds are distinct from St. Louis-based Ascend Venture Capital.

Ubiquity Ventures is a seed-stage venture capital firm investing in software that operates beyond computer screens in physical industries. It backs technical founders building AI, robotics, sensing and software systems for agriculture, climate, space, healthcare, industrial operations and security, with a focus on commercially practical deep technology and hands-on support from its investing team and extended operator network.

Consumer-robotics operating company associated with Roomba robot vacuum products. Corporate investments do not make the parent identity a standalone venture capital manager; this classification does not assert its current ownership or restructuring status.

Sompo Holdings, Inc. is the Japanese listed insurance holding company established on April1,2010, headquartered at26-1 Nishi-Shinjuku1-chome, Shinjuku-ku, Tokyo. Its official corporate profile identifies management of insurance companies and other controlled subsidiaries under Japan’s insurance legislation and a Tokyo Stock Exchange Prime Market listing. The group combines domestic and international property-and-casualty insurance, life insurance and nursing care, with wellbeing and digital businesses. Its existing database category InvestmentFirm is retained as an immutable legacy classification; the actual institution is a publicly traded corporate holding company, not an independent third-party venture manager. Sompo Japan, Sompo International, Sompo Himawari Life, Sompo Care, Sompo Health Support and Palantir Technologies Japan are distinct operating companies, not aliases for the parent. Sompo is relevant to AI, deep technology and neuroscience through its corporate digital strategy, insurance technology, data platforms and cognitive-health investments. Its own digital-strategy reporting describes technology adoption, AI and generative-AI systems, and operational and healthcare data applications. The current parent leadership explicitly includes digital and new-business investment responsibilities, co-chief digital officers, a chief data officer and a wellbeing Chief Digital & AI Officer. SOMPO Digital Lab is a group innovation programme; the reviewed programme links do not establish a separately closed third-party LP fund. Corporate capital, programme budgets, commercial partnerships, acquisitions and technology spending are not classified as venture-fund subscriptions. The official October1,2026 directory lists11 directors and28 executive-officer/vice-president entries, with three executives also on the board:36 distinct published leaders. This profile includes the complete current parent board and executive directory, scoped to those roles rather than all group staff. The parent publishes authentic portraits and professional biographies for the11 board members; portraits and full career histories for the other25 executive-only members are not supplied by the reviewed directory. Concurrent subsidiary titles identify responsibilities without automatically creating separate employer records or personal investments. Mikio Okumura is Group CEO, president and representative executive officer; Shinichi Hara is Group CHRO and Katsuyuki Tajiri Group CFO. Kazuhiro Higashi chairs the board as an independent outside director. Neurotrack’s own June11,2019 announcement names Sompo Holdings as a new participant in its USD21M SeriesC, establishing a specific cognitive-health investment distinct from commercial deployment by group life insurers. Existing Sompo participation26958 on canonical event14648 is retained. Historical mirror participation18153/event12132 is preserved as the same economic event with mirror cash unbooked under the issuer’s separate audit; it is not a second Sompo investment. All five prior participation IDs and their existing financial and attribution payloads are preserved. The two old Palantir-labelled issuer records and Intuition Robotics record remain protected and require separate full-source issuer/alias audits before any consolidation. Individual corporate tickets, subscribing subsidiaries and venture-vehicle allocations are not inferred from parent-brand names. No unsupported LP fund, closed fund amount, commercial-contract value or personal check is added.

Axon Partners Group is a Madrid-based investment and consulting group specialising in technology and innovation. Its investment platform backs growing technology companies, climate and industrial technologies, and venture capital funds through regional and international vehicles. Its consulting division advises businesses, investors and public bodies on technology strategy, telecommunications, digital policy, market regulation and business modelling. Its regulated Spanish fund manager is the separate legal entity Axon Partners Group Investment, SGEIC, SA.

CASSIUS is an early-stage venture capital firm investing at the intersection of consumer products and technology across the United States and Europe. Founded by Emmanuel Seugé in 2017, it backs founders building software, AI products, digital media, gaming, marketplaces and consumer brands, with particular experience helping European-founded companies expand internationally. Its principals combine Seugé’s brand-building and corporate-investment experience at Coca-Cola with Jean de La Rochebrochard’s early-stage investing background at Kima Ventures. The firm works with founders over time through investment, board involvement and company-building support. CASSIUS Management Company, LLC is the SEC-reported adviser associated with its official website and recent U.S. venture vehicles; each fund and general partner remains a distinct legal entity.

Redstone is a European early-stage venture capital firm that invests through specialist strategies in deep tech, industrial technology, energy and infrastructure, fintech, health, social impact, the blue economy and venture debt. It uses sector expertise and its Sofia data platform to source and evaluate companies, and supports founders with operating guidance and industry networks. Its deep-tech investments cover AI, photonics, robotics, connectivity and novel computing; its Nordic ocean strategy backs marine intelligence, autonomous systems, clean energy, blue biotechnology and water technologies.

ALS Investment Fund is an Amsterdam-based venture-capital platform investing in biotechnology companies developing treatments for neurodegenerative diseases, with a particular focus on amyotrophic lateral sclerosis (ALS). The platform combines scientific diligence and clinical-development expertise with private investment in therapies and technologies addressing disease mechanisms, brain delivery and drug discovery. Its current public roster includes scientific and investment partners, investment/advisory committee affiliations, investor relations, compliance, finance and scientific due diligence. The legal investment manager is SUNU Ventures B.V., confirmed by official fund documents and its April4,2025 SEC Form ADV, CRD333021/SEC802-131160. Its own disclaimer identifies the Dutch small-manager registration regime; this is not a claim of a full AFM investment-management licence. The ALS Investment Fund brand, SUNU manager, ALS Investment Fund III cooperative and numbered single-company investment vehicles are related but distinct legal concepts. Fund III’s December1,2025 announcement reports approximately USD70 million raised across the core fund and additional deal-specific co-investor LPs, with the core-only amount undisclosed. A December2019 ALS Association partnership reported USD25 million raised by the predecessor fund and a USD100 million target for Fund II; the latter is not a verified actual close. National ALS charities and foundations remain distinct institutions, although some support the strategy as LPs. Company investments and historical exits are sourced separately, with no assumed buyer ticket or allocation to a specific private fund. QurAlis expressly names ALS Investment Fund as an additional participant, rather than a lead, in its March9,2023 USD88 million Series B.

Artesian is a global alternative investment manager founded in Sydney in 2004, operating distinct fixed-income and venture-capital businesses. Its debt strategies invest in corporate, green and sustainable bonds and other credit instruments. Its venture platform backs early-stage companies across energy transition, agrifood, health, artificial intelligence and autonomy, defence, and frontier technologies, including hardware and applied science. It also designs and manages dedicated venture funds for institutional backers through its Venture Capital as a Service model, handling sourcing, diligence, investment decisions, portfolio support and fund operations. The firm works with governments, corporations, pension and superannuation funds, universities, wealth managers and family offices.

Atlantic Bridge is a growth-equity and venture-investment platform founded in2004, investing in deep-technology businesses in Europe, the UK and the United States. Its Bridge Model supports cross-border commercial expansion, international customer access, senior team development and active portfolio management. Focus areas include AI and advanced computing, cybersecurity, enterprise software, next-generation semiconductors, advanced manufacturing, health technology, climate and sustainability. The University Bridge Funds commercialise research-led companies from Irish universities and institutions, including quantum computing, AI and neurotechnology. Its live portfolio identifies Aizon, Equal1, SambaNova, Vectra, Luma Vision, Syntiant and other technology companies. Own privacy disclosures identify Atlantic Bridge Services Limited as website operator; the UK registry identifies Atlantic Bridge Capital LLP OC308675, formerly Atlantic Bridge Ventures LLP, as a related legal manager entity. A brand-level portfolio relationship does not establish the subscribing partnership or fund in every deal. The full35-person published investment/advisor/operations roster is recovered from the firm’s March22,2025 archived directory; the current site no longer publishes that team page, so those roles are explicitly dated published affiliations rather than an assertion all remain current. Reported group assets under management and company fundraising totals are not fund closes. Existing manager identity, investor3105 and all earlier investment links are retained.

Baseline Ventures is the US seed-stage technology investment manager founded by Steve Anderson in2006. Its own founder statement describes financing the gap between individual angels and institutional venture funds and identifies investments across software, consumer technology and enterprise infrastructure. Its public portfolio includes AI and advanced analytics (Figure), autonomous construction robotics (Dusty Robotics), security and developer/data infrastructure. Portfolio product claims are source-published company descriptions rather than independently benchmarked capabilities. The exact SEC-reporting manager is Baseline Industries, L.P., doing business as Baseline Ventures, CRD294309 and exempt-reporting file802-112980. Its latest reviewed Form ADV annual amendment is31March2026 and lists Jackson, Wyoming as principal office. The own LinkedIn Ross, California address is source-aged context, not substituted for the current filing. SEC exempt reporting does not establish SEC registration. The Indian athlete-management company at baselineventures.com and other same-name LLC/Inc businesses are distinct; the verified US fund website is baselinev.com. The own website publishes founder Steve Anderson with an authentic named portrait and career background spanning eBay, Microsoft, Kleiner Perkins, Starbucks and Digital Equipment Corporation. SEC ScheduleA identifies the same person as Steven Anderson, CRD6049236, managing member of Baseline Industries GP, LLC and related fund GP/manager entities. No other names are made partners merely because LinkedIn aggregates people at same-name companies. The public founder scope is complete; undisclosed operations staff are not invented. Former portfolio board seats and unrelated Anderson homonyms are not inferred current roles. The31March2026 SEC filing reports ten exact legal private funds, including Baseline Core Fund, Baseline Ultra Core, Baseline2223 and historical seed/exposure/growth vehicles. Their reported gross asset values and investor minimum commitments are not fund raises, capital commitments or actual LP cash closings. No source-proven actual closing amount/day is assigned from those values. Secondary headlines about USD133million in2020 or cumulative USD500million are not promoted to verified close records without primary offering evidence. Exact portfolio subscribing vehicles remain distinct from the manager and are not guessed from fund vintages. Own portfolio material documents both investments and exits; the founder reports more than100 backed companies and more than50 profitable exits. Those undated career totals do not imply100 active current holdings, proven personal checks, or new financing events. Existing18 investment participations and their provenance are preserved while Dusty Robotics issuer financing links are handled by the company’s dedicated audit.

Foundation Capital is a venture capital firm that partners with founders from company formation and seed stage, frequently before products or revenue exist. It invests in AI and enterprise software, financial technology, cybersecurity and crypto infrastructure, and supports portfolio companies with product and market strategy, recruiting, marketing and fundraising through its investing team, portfolio services and Build accelerator programs.

OpenOcean is a pan-European venture capital firm backing Seed and early Series A companies that build data-intensive software and deep technology. It leads or co-leads investments in AI infrastructure, developer tools, AI-enabled services, business automation and quantum technologies that enable scalable computation. The team draws on experience building MySQL, MariaDB and other technology businesses to help founders develop products, recruit, build commercial networks and scale internationally. It publishes initial investment tickets of up to €5 million and has offices in Helsinki and London. OpenOcean is an investing brand spanning several regulated fund-management and general-partner companies; OpenOcean Oy manages its Fund 2024 Ky.

Global multi-stage venture capital firm investing across India, APAC, the United States and other innovation hubs.

Specialty finance and investment firm providing venture debt and other capital solutions to venture-backed growth companies.

DHVC, historically Danhua Capital, is a Silicon Valley venture-capital platform founded in2013 by Andrew (Anjia) Gu and Stanford physicist Shoucheng Zhang. Its investing has covered artificial intelligence, enterprise software, big data, augmented and virtual reality, blockchain and healthcare, including computational drug discovery at Engine Biosciences. The current March2026SEC filing identifies adviser Danhua Capital Management LLC, CRD170108, as an exempt reporting adviser based inMenloPark, with Anjia Gu as managing member. Danhua Capital LP and Danhua Capital II LP are separate Delaware private funds with distinct GP LLCs; the manager brand, US fund vehicles and Chinese institutional collaborators are not treated as one legal cash investor. Zhongguancun Development Group independently describes participation in the first and second phases of the historic Danhua fund. The official domain dh.vc is currently disconnected, so the recovered January2020official team directory and native DHVC logo are explicitly archival. Andrew Gu’s management capacity is independently confirmed by the current regulatory filing. Historical Kevin Ding, Judy Yan and Ali Farahanchi roles do not imply current employment; Ali’s later Engine biography identifies Camford Capital. Zhang died in2018 and is recorded only historically. FundI reported USD91.25M fully sold with zero remaining inJune2014; FundII reported USD250M sold against255Moffering inAugust2016, an interim amount rather than a proven final close. GAV, reported assets managed, targets and successor or China-linked vehicles are excluded from new cash claims.

Crosslink Capital is the US investment adviser legally Crosslink Capital, Inc., SEC-registered under CRD109948 and file801-56860. Its own legal terms and March27,2026 FormADV establish the exact manager identity. Founded in1989, it invests in early-stage enterprise, consumer and vertical technology companies, including AI healthcare and manufacturing software. Its platform also has separately published public-market and crossover investment professionals. The current two directories publish33 unique people spanning investment, public/crossover, operations, advisers/EIRs and Alpha network staff; these capacities are distinguished rather than treating every adviser or community operator as an employee or company director. Alpha, co-founded by Eric Chin in2005, is an invitation-only founder and operator network, not a separate inferred pooled fund or duplicate cash buyer. Crosslink closed its tenth flagship venture fund, Crosslink VenturesX, with USD350M capital commitments as announced April23,2024; the same release confirms the predecessor fund had USD350M in January2021. Registered fund net assets and gross asset values are not assumed original fundraising closes. The manager has actual Aizon (formerly Bigfinite) equity participation in the2017 seed and subsequent2019/2024 financings; individual allocations remain undisclosed. Existing Crosslink investor3059 and all legacy investments and shared person roles are preserved.

Harpoon Ventures backs early-stage companies in AI, deep tech, defense, cybersecurity, energy and biotechnology. It helps founders develop commercial markets and navigate US government customers and procurement.